772
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Conservative versus active management in HELLP syndrome: results from a cohort study

, , , , , & show all
Pages 1769-1775 | Received 24 Nov 2017, Accepted 10 Dec 2017, Published online: 21 Dec 2017

References

  • Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142:159–167.
  • Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004;103:981–991.
  • Abramovici D, Friedman SA, Mercer BM, et al. Neonatal outcome in severe preeclampsia at 24 to 36 weeks’ gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol. 1999;180:221–225.
  • van Pampus MG, Wolf H, Westenberg SM, et al. Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol. 1998;76:31–36.
  • van Pampus MG, Wolf H, Ilsen A, et al. Maternal outcome following temporizing management of the (H)ELLP syndrome. Hypertens Pregnancy. 2000;19:211–220.
  • Moussa HN, Arian SE, Sibai BM. Management of hypertensive disorders in pregnancy. Womens Health (Lond). 2014;10:385–404.
  • Tompkins MJ, Thiagarajah S. HELLP (Hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids. Am J Obstet Gynecol. 1999;181:304–309.
  • O’Brien JM, Milligan DA, Barton JR. Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol. 2000;183:921–924.
  • Woudstra DM, Chandra S, Hofmeyr GJ, et al. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev. 2010;9:CD008148:CD008148.
  • Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993;169:1000–1006.
  • Weinstein L. Preeclampsia/eclampsia with hemolysis, elevated liver enzymes, and thrombocytopenia. Obstet Gynecol. 1985;66:657–660.
  • Magee LA, Yong PJ, Espinosa V, et al. Expectant management of severe preeclampsia remote from term: a structured systematic review. Hypertens Pregnancy. 2009;28:312–347.
  • Martin JN Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol. 2006;195:914–934.
  • Visser W, Wallenburg HC. Temporising management of severe pre-eclampsia with and without the HELLP syndrome. BJOG. 1995;102:111–117.
  • Publications Committee, Society for Maternal-Fetal Medicine, Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks’ gestation. Am J Obstet Gynecol. 2011;205:191–198.
  • Harms K, Rath W, Herting E, et al. Maternal hemolysis, elevated liver enzymes, low platelet count, and neonatal outcome. Am J Perinatol. 1995;12:1–6.
  • Roelofsen AC, van Pampus MG, Aarnoudse JG. The HELLP-syndrome; maternal-fetal outcome and follow up of infants. J Perinat Med. 2003;31:201–208.
  • Nisell H, Palm K, Wolff K. Prediction of maternal and fetal complications in preeclampsia. Acta Obstet Gynecol Scand. 2000;79:19–23.
  • Chard T, Penney G, Chalmers J. The risk of neonatal death in relation to birth weight and maternal hypertensive disease in infants born at 24–32 weeks. Eur J Obstet Gynecol Reprod Biol. 2001;95:114–118.
  • Newman MG, Robichaux AG, Stedman CM, et al. Perinatal outcomes in preeclampsia that is complicated by massive proteinuria. Am J Obstet Gynecol. 2003;188:264–268.
  • van Runnard Heimel PJ, Franx A, Schobben AF, et al. Corticosteroids, pregnancy, and HELLP syndrome: a review. Obstet Gynecol Surv 2005;60:57–70.
  • Martin JN Jr, Owens MY, Keiser SD, et al. Standardized Mississippi Protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity. Hypertens Pregnancy. 2012;31:79–90.
  • Katz L, Amorim M, Souza JP, et al. COHELLP: collaborative randomized controlled trial on corticosteroids in HELLP syndrome. Reprod Health. 2013;10:28.
  • Haram K, Mortensen JH, Mastrolia SA, et al. Disseminated intravascularcoagulation in the HELLP syndrome: how much do we really know? J Matern Fetal Neonatal Med. 2017;30:779–788.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.